Greffex Inc.

Aurora, CO

UEI
ZJ9LM42X21Q2
CAGE
610R0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Veteran Owned Business
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
12635 E Montview Blvd #308, Aurora, CO 80045, USA
Website
greffex.com
Founded
1999
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Greffex Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of an usher gene therapy - summary mutations in the USH2A gene are the cause of the usher syndrome type II… Grant · R43EY031603 National Eye Institute $902,455
To make an award under HHS-NIH-niaid-BAA2018 Contract · 75N93019C00061 National Institute of Allergy and Infectious Diseases $11,246,915

Quick answers

What is Greffex Inc.'s UEI?

Greffex Inc.'s Unique Entity ID (UEI) in SAM.gov is ZJ9LM42X21Q2.

What is Greffex Inc.'s CAGE code?

Greffex Inc.'s CAGE code is 610R0.

What is Greffex Inc.'s primary NAICS code?

Greffex Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Greffex Inc. located?

Greffex Inc.'s physical address in SAM.gov is 12635 E Montview Blvd #308, Aurora, CO 80045, USA.

Is Greffex Inc. registered in SAM.gov?

Yes. Greffex Inc.'s SAM.gov registration is active through July 30, 2027.

What is Greffex Inc.'s most recent federal award?

Greffex Inc.'s most recent federal grant award is Development of an usher gene therapy - summary mutations in the USH2A gene are the cause of the usher syndrome type II… (R43EY031603), from National Eye Institute, on March 1, 2021.

On GovTribe

See Greffex Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login